<div id="readability-page-1"><p>Barclays analyst Glen Santangelo maintained a Buy rating on Hims &amp; Hers Health today and set a price target of $29.00.</p><h3>Claim 55% Off TipRanks</h3><ul><li>Unlock  hedge fund-level data  and  powerful investing tools  for smarter, sharper decisions  </li><li> Discover top-performing stock ideas and upgrade to a portfolio of market leaders with  Smart Investor Picks  </li></ul> <p>According to TipRanks, Santangelo is a 4-star analyst with an average return of <span>3.5%</span> and a 49.50% success rate. Santangelo covers the Healthcare sector, focusing on stocks such as Cencora, Henry Schein, and Medline.</p> <p>In addition to Barclays, Hims &amp; Hers Health also received a Buy from J.P. Morgan’s Cory Carpenter in a report issued on April 24. However, on May 5, Deutsche Bank  assigned a Hold rating to Hims &amp; Hers Health (NYSE: HIMS).</p></div>

HIMS

HIMZ

HIMY

<p>Barclays analyst Glen Santangelo has maintained a Buy rating on Hims & Hers Health (HIMS) with a price target of $29.00. Santangelo, a 4-star analyst, has an average return of 3.5% and a 49.50% success rate. Hims & Hers Health also received a Buy rating from J.P. Morgan's Cory Carpenter, while Deutsche Bank assigned a Hold rating on May 5.</p>

Tip Ranks

Hims & Hers Health

VG Health

Defiance Daily Target 2X Long HIMS ETF

iShares US Healthcare Providers

Defiance Leveraged Long +Income HIMS ETF

Barclays

Cencora

Henry Schein

Medline

JPMorgan Chase

Deutsche Bank AG

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

Deutsche Bank AG Subscription Rights

Deutsche Postbank AG

Hims & Hers Health (HIMS) Gets a Buy from Barclays